Green D, Blanc J, Foiles N
Northwestern Hemophilia Center, Department of Medicine, Northwestern University Medical School, Chicago, Illinois, USA.
J Lab Clin Med. 1999 Mar;133(3):260-4. doi: 10.1016/s0022-2143(99)90082-3.
Autoantibodies to factor VIII (FVIII)(spontaneous inhibitors) often inactivate FVIII in a complex fashion (type II inhibitors) as compared with alloantibodies (hemophilic inhibitors), which usually demonstrate second-order reaction kinetics (type I inhibitors). The infusion of porcine FVIII in patients with spontaneous inhibitors may give rise to anti-porcine FVIII antibodies. The purpose of this study was to determine whether these were type I or type II inhibitors. Plasma from 8 patients with spontaneous inhibitors and 6 patients with hemophilia with inhibitors were studied. Equal volumes of patient plasma and either pooled normal human plasma or porcine FVIII (Hyate-C) were incubated at 37 degrees C for 90 minutes. Aliquots were removed immediately after mixing and at 30-minute intervals and assayed for FVIII by using a two-stage method. The values for residual FVIII were log-transformed and plotted against the time of incubation, and the resultant curves were analyzed for goodness of fit (coefficient of determination, r2) by using linear and exponential equations. The values were examined by paired t tests; P values were two-tailed. Values are expressed as mean +/- SD. The titers of spontaneous inhibitors against human FVIII ranged from 2.6 to 416 Bethesda Units (BU), and those against porcine FVIII ranged from 0.7 to 47 BU. Samples were diluted so that the FVIII levels in the mixtures before incubation were similar: human, 0.44 U/ml; porcine, 0.47 U/ml; P = not significant. Four of the 8 patients with spontaneous inhibitors inactivated human FVIII in a fashion consistent with complex kinetics; their r2 values with the linear equation were less than 0.90. All r2 values improved when the exponential equation was used (linear, 0.90 +/- 0.08; exponential, 0.92 +/- 0.06; P = .007). In contrast, r2 values with porcine FVIII were the same (0.94) with either the linear or the exponential equation (P = not significant). r2 for the 6 hemophilic inhibitors showed no significant difference between the linear and exponential equations; the values were 0.99 with human FVIII and 0.95 with porcine FVIII. In non-hemophilic patients, antibodies developing to porcine FVIII have kinetics of inhibition that are second order (type I), even though antibodies to human FVIII in these same patients may have complex (type II) kinetics.
与通常表现为二级反应动力学(I型抑制剂)的同种抗体(血友病抑制剂)相比,针对凝血因子VIII(FVIII)的自身抗体(自发抑制剂)通常以复杂方式使FVIII失活(II型抑制剂)。在有自发抑制剂的患者中输注猪FVIII可能会产生抗猪FVIII抗体。本研究的目的是确定这些是I型还是II型抑制剂。对8例有自发抑制剂的患者和6例有抑制剂的血友病患者的血浆进行了研究。将等量的患者血浆与混合的正常人血浆或猪FVIII(Hyate-C)在37℃孵育90分钟。混合后立即及每隔30分钟取出等分试样,采用两阶段法检测FVIII。将残余FVIII的值进行对数转换,并针对孵育时间作图,然后使用线性和指数方程分析所得曲线的拟合优度(决定系数,r2)。通过配对t检验检查这些值;P值为双侧。数值表示为平均值±标准差。自发抑制剂针对人FVIII的滴度范围为2.6至416贝塞斯达单位(BU),针对猪FVIII的滴度范围为0.7至47 BU。对样品进行稀释,以使孵育前混合物中的FVIII水平相似:人,0.44 U/ml;猪,0.47 U/ml;P = 无显著性差异。8例有自发抑制剂的患者中有4例以符合复杂动力学的方式使人类FVIII失活;它们与线性方程的r2值小于0.90。当使用指数方程时,所有r2值均有所改善(线性方程,0.90±0.08;指数方程,0.92±0.06;P = 0.007)。相比之下,使用线性或指数方程时,猪FVIII的r2值相同(0.94)(P = 无显著性差异)。6例血友病抑制剂的r2值在使用线性和指数方程时无显著差异;人FVIII时的值为0.99,猪FVIII时的值为0.95。在非血友病患者中,针对猪FVIII产生的抗体具有二级抑制动力学(I型),尽管这些患者中针对人FVIII的抗体可能具有复杂(II型)动力学。